Your session is about to expire
← Back to Search
OCS-01 for Macular Edema (LEOPARD Trial)
LEOPARD Trial Summary
This trial is studying a new kind of steroid eye drops to see if it can help those with macular edema due to Uveitis or eye surgery.
LEOPARD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 4 trial • 122 Patients • NCT01474915LEOPARD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My dose of immunosuppressants has not increased in the last 2 months.I can use eye drops for high eye pressure if needed during the study.I have diabetic retinopathy.I have taken more than 10 mg of prednisone daily in the last month.I have an eye condition that significantly lowers my vision.My eye pressure goes up with steroid eye drops.I have had an eye infection called uveitis before.My dose of oral prednisone has been stable for the last month.My macular edema is not caused by UME or PSME.I have an active eye or area around the eye infection.I tried a skin cream for pain or swelling without success for 1 to 3 months.I have active inflammation in my eye.I am 18 years old or older.My vision loss is not mainly due to UME or PSME.My eye condition has lasted less than a year and involves fluid buildup.I have been diagnosed with swelling in the macula due to uveitis or after surgery.If both my eyes qualify, the one with poorer vision or my non-dominant eye will be chosen for the study.I have been treated with more than 2 immunosuppressives in the last 2 months.I have glaucoma with severe optic nerve damage or high eye pressure despite using 3 or more medications.My eye inflammation is currently inactive or stable.
- Group 1: High Dose UME - 6 drops OCS-01
- Group 2: Low Dose UME 3 drops OCS-01 and 3 drops Placebo
- Group 3: High dose PSME - 6 drops of OCS-01
- Group 4: Low dose PSME - 3 drops of OCS-01 and 3 drops of Placebo
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum number of participants accepted for this clinical trial?
"Confirmatively, clinicaltrials.gov verifies that this investigation is currently seeking volunteers. It was originally posted on the 26th of May 2023 and last updated on 5 June 2023. This trial needs a total of 24 participants from 4 different locations."
How many venues are currently undertaking this trial?
"Currently, this medical trial is being held at 4 sites, with Palo Alto and McAllen as two of the locales. Plano and four additional destinations are also implementing the study. To avoid extended travel periods while participating in the research, patients should select a nearby clinic to attend."
What have the findings been in terms of patient safety related to high dose PSME - 6 drops of OCS-01?
"There is a moderate amount of evidence suggesting the safety of High dose PSME - 6 drops of OCS-01, so it was assigned a score of 2. Unfortunately, there are no studies that have established efficacy for this medication yet."
Is this laboratory research accepting new participants?
"Affirmative. Clinicaltrials.gov has documented that this clinical trial, which was first posted on May 26th 2023, is still actively recruiting participants from 4 different sites with a total of 24 required enrollees."
Share this study with friends
Copy Link
Messenger